Super
Turkey Tail
Maintain your immune system throughout
the year, not only during Thanksgiving Holidays.
Turkey Tail (Coriolus) belongs to the
family polyporaceae, and its immune-enhancing activities have
been extensively studied in Japan since mid 1970's (over 300
clinical studies have been conducted)*. Active compounds in
Coriolus are widely recognized as PSK in Japan.
Vegetable
Tablet,
Net Weight: 575mg
Turkey Tail Fruit Body, Turkey Tail Extract 20:1, Ginger,
Maitake D-fraction Extract 10%, Vitamin C and Bioperine.
120 Tablets.
 Turkey
Tail (Coriolus versicolor) is historically known in
China as Yun Zhi and in Japan as Kawaratake and may be the
most studied medicinal mushroom among all. From this mushroom,
PSK (polysaccharide-Krestin) was extracted in Japan in 1965
and PSP (polysaccharide-peptide) in China in 1984. In Japanese
trials, PSK significantly extended survival rates in cancer of
stomach, colon-rectum, esophagus, nasopharynx and lung. In
1977, PSK was approved by the Japanese Ministry of Health and
Welfare to use for cancer treatment as the first
polysaccharide anti-tumor drug from mushroom. PSP showed not
only anti-tumor effect but also the abilities to fight with
anti-virus and anti-inflammation including hepatitis B and
chronic active hepatitis.
Bioactive
constituents
Bata-glucan
protein complex, Heteroglucan-peptide
Bioactivities
1.) Anti-tumor: Immune enhancement such as activating
macrophage, T-cell and NK-cell, Enhancing serum C3 and 1gG,
Promoting lymphocyte proliferation and increasing the
production of interleukins and interferon
2.) Anti-hepatitis: Lowering GPT and GOT, Recovering the
damaged liver cell and normalizing the liver functions,
Minimizing the symptoms of hepatitis and cirrhosis
References:
(1) T. Ikekawa et al, Gann (Japanese), 54:155 (1968); Cancer
Res., 29:734 (1960)., (2) T. Miyazaki et al, Chem. Pharm.
Bull., 22:1739 (1974)., (3) R. Ohno et al, Gann (Japanese)
66:679 (1975)., (4) W. Shao et al, Pharmaceutical Industry,
2:25 (1980)., (5) S. Tsukagoshi et al, Cancer Treatment
Reviews, 11:131 (1984)., (6) Q.Y. Yang et al, J. Shanghai
(Chinese), 4:36 (1986)., (7) X.M. Li et al, Acto Acad. Med.
Shanghai (Chinese), 14:23 (1987)., (8) S. Hirase, PSK Krestin,
Excerpta Medica, (1988)., (9) M. Ikuzawa et al, Int. J. of
Immunopharmacology, 10(4):415 (1988)., (10) M. Torisu et al,
Cancer Immunology Immunotherapy 31(5):261 (1990)., (11) M.
Yang et al, Amer. J. Chin. Med. 20:221 (1992)., (12) K.
Hayakawa et al, Anticancer Research, 13:1815 (1993)., (13) Y.
Lino et al, Anticancer Research, 15:2907 (1995).
Directions
These
statements have not been evaluated by the Food and
Drug Administration. This product is not intended to
diagnose, treat, cure or prevent any disease.
|
|
